A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.Michael A. Morse, H. Kim Lyerly, E. Kitrell-Fisher et al.|PubMed|1999Cited by 300